StemCell Institute (TSE:7096) EV-to-EBITDA : 20.90 (As of May. 31, 2025)

StemCell Institute EV-to-EBITDA Chart

StemCell Institute Quarterly Data
	Mar18	Mar19	Dec19	Mar20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
EV-to-EBITDA	Get a 7-Day Free Trial													95.95	66.53	49.13	32.78	69.34

Competitive Comparison of StemCell Institute's EV-to-EBITDA

For the Biotechnology subindustry, StemCell Institute's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

StemCell Institute's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, StemCell Institute's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where StemCell Institute's EV-to-EBITDA falls into.

StemCell Institute EV-to-EBITDA Calculation

StemCell Institute's EV-to-EBITDA for today is calculated as:

StemCell Institute's current Enterprise Value is 円8,647 Mil.
StemCell Institute's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円414 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

StemCell Institute  (TSE:7096) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

StemCell Institute's PE Ratio (TTM) for today is calculated as:

StemCell Institute's share price for today is 円1129.00.
StemCell Institute's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円30.345.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

StemCell Institute EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of StemCell Institute's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

StemCell Institute Business Description